檢索結果 - Colin D. Weekes

Refine Results
  1. 1
    Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities

    Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities 由 Laura M. Spring, Erika Nakajima, Jennifer Hutchinson, Elene Viscosi, Gayle C. Blouin, Colin D. Weekes, Hope S. Rugo, Beverly Moy, Aditya Bardia

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Patient-derived tumour xenografts as models for oncology drug development

    Patient-derived tumour xenografts as models for oncology drug development 由 John J. Tentler, Aik Choon Tan, Colin D. Weekes, Antonio Jimeno, Stephen Leong, Todd M. Pitts, John J. Arcaroli, Wells A. Messersmith, Sabine Eckhardt

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer

    Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreat... 由 Wen Wee, Wells A. Messersmith, Grace K. Dy, Colin D. Weekes, Amy Whitworth, Chen Ren, Manoj Maniar, François Wilhelm, Sabine Eckhardt, Alex A. Adjei, Antonio Jimeno

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming

    CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming 由 Agnieszka A. Kendrick, Johnathon Schafer, Monika Dzieciątkowska, Travis Nemkov, Angelo D’Alessandro, Deepika Neelakantan, Heide L. Ford, Chad G. Pearson, Colin D. Weekes, Kirk C. Hansen, Elan Eisenmesser

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

    A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors 由 Colin D. Weekes, A. Craig Lockhart, Patricia LoRusso, Elaine Murray, Erica Park, Mike Tagen, Jatinder Singh, Indrani Sarkar, Lars Müeller, Hatem Dokainish, Geoffrey I. Shapiro, Howard A. Burris

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

    Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma 由 Aaron J. Grossberg, Linda C. Chu, Christopher R. Deig, Eliot Fishman, William L. Hwang, Anirban Maitra, Daniel L. Marks, Arnav Mehta, Nima Nabavizadeh, Diane M. Simeone, Colin D. Weekes, Charles R. Thomas

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly <i>nab-</i>Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer

    Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly <i>nab-</i>Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancrea... 由 Josep Tabernero, E. Gabriela Chiorean, Jeffrey R. Infante, Sunil R. Hingorani, Vinod Ganju, Colin D. Weekes, Werner Scheithauer, Ramesh K. Ramanathan, David Goldstein, Darryl Penenberg, Alfredo Romano, Stefano Ferrara, Daniel D. Von Hoff

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors

    First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors 由 John H. Strickler, Colin D. Weekes, John Nemunaitis, Ramesh K. Ramanathan, Rebecca S. Heist, Daniel Morgensztern, Eric Angevin, Todd M. Bauer, Huibin Yue, Monica Motwani, Apurvasena Parikh, Edward B. Reilly, Daniel Afar, Louie Naumovski, Karen Kelly

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

    Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer 由 Efrat Dotan, Dana B. Cardin, Heinz‐Josef Lenz, Wells A. Messersmith, Bert H. O’Neil, Steven J. Cohen, Crystal S. Denlinger, Safi Shahda, Igor Astsaturov, Ann M. Kapoun, Rainer K. Brachmann, Shailaja Uttamsingh, Robert Stagg, Colin D. Weekes

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer

    A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer 由 Adrian Murphy, Marianna Zahurak, Mirat Shah, Colin D. Weekes, Aaron R. Hansen, Lillian L. Siu, Anna Spreafico, Noelle K. LoConte, Nicole M. Anders, T. Miles, Michelle A. Rudek, L. Austin Doyle, Barry D. Nelkin, Anirban Maitra, Nilofer S. Azad

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm

    The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm 由 Amna Zafar, Zsófia D. Drobni, Ramya Mosarla, Raza M. Alvi, Matthew Lei, Uvette Lou, Vineet K. Raghu, Sean Murphy, Maeve Jones‐O’Connor, Sarah Hartmann, Hannah Gilman, Colin D. Weekes, John R. Clark, Jeffrey W. Clark, Lawrence S. Blaszkowsky, Erica Tavares, Tomas G. Neilan

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

    A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor 由 Johanna C. Bendell, Milind Javle, Tanios Bekaii‐Saab, Richard S. Finn, Zev A. Wainberg, Daniel A. Laheru, Colin D. Weekes, Benjamin Tan, Gazala Khan, Mark M. Zalupski, Jeffrey R. Infante, Suzanne F. Jones, Kyriakos P. Papadopoulos, Anthony W. Tolcher, Renae Chavira, Janna Christy‐Bittel, Emma Barrett, Amita Patnaik

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Phase I Study of Oral Rigosertib (ON 01910.Na), a Dual Inhibitor of the PI3K and Plk1 Pathways, in Adult Patients with Advanced Solid Malignancies

    Phase I Study of Oral Rigosertib (ON 01910.Na), a Dual Inhibitor of the PI3K and Plk1 Pathways, in Adult Patients with Advanced Solid Malignancies 由 Daniel W. Bowles, Jennifer R. Diamond, Elaine T. Lam, Colin D. Weekes, David P. Astling, Ryan T. Anderson, Stephen Leong, Lia Gore, Marileila Varella‐Garcia, Brian W. Vogler, Stephen B. Keysar, Elizabeth Freas, Dara L. Aisner, Chen Ren, Aik Choon Tan, François Wilhelm, Manoj Maniar, Sabine Eckhardt, Wells A. Messersmith, Antonio Jimeno

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

    Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial 由 Shubham Pant, Zev A. Wainberg, Colin D. Weekes, Muhammad Furqan, Pashtoon Murtaza Kasi, Craig Devoe, Alexis D. Leal, Vincent Chung, Olca Baştürk, Haley VanWyk, Amy Tavares, Lochana M. Seenappa, James Perry, Thian Kheoh, Lisa K. McNeil, Esther Welkowsky, Peter C. DeMuth, Christopher M. Haqq, Eileen M. O’Reilly

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer

    Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer 由 Colin D. Weekes, Daniel D. Von Hoff, Alex A. Adjei, Diane P. Leffingwell, Sabine Eckhardt, Lia Gore, Karl D. Lewis, Glen J. Weiss, Ramesh K. Ramanathan, Grace K. Dy, Wen Wang, Beth Sheedy, Cory Iverson, Jeffrey N. Miner, Zancong Shen, Li‐Tain Yeh, Ronald L. Dubowy, Michael Jeffers, Prabhu Rajagopalan, Neil J. Clendeninn

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy

    Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy 由 Theodoros Michelakos, Lei Cai, Vincenzo Villani, Francesco Sabbatino, Filippos Kontos, Carlos Fernández-del Castillo, Teppei Yamada, Azfar Neyaz, Martin S. Taylor, Vikram Deshpande, Tomohiro Kurokawa, David T. Ting, Motaz Qadan, Colin D. Weekes, Jill N. Allen, Jeffrey W. Clark, Theodore S. Hong, David P. Ryan, Jennifer Y. Wo, Andrew L. Warshaw, Keith D. Lillemoe, Soldano Ferrone, Cristina R. Ferrone

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)

    Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcino... 由 Dung T. Le, Vincent J. Picozzi, Andrew H. Ko, Zev A. Wainberg, Hedy L. Kindler, Andrea Wang‐Gillam, Paul E. Oberstein, Michael A. Morse, Herbert J. Zeh, Colin D. Weekes, Tony Reid, Erkut Borazanci, Todd S. Crocenzi, Noelle K. LoConte, Benjamin Musher, Dan Laheru, Aimee Murphy, Chan C. Whiting, Nitya Nair, Amanda Enstrom, Sandy Ferber, Dirk G. Brockstedt, Elizabeth M. Jaffee

    出版 2019
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  18. 18
    Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer

    Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer 由 Susan G. R. McDuff, Karin M. Hardiman, Peter Ulintz, Aparna R. Parikh, Hui Zheng, Daniel W. Kim, Jochen K. Lennerz, Mehlika Hazar-Rethinam, Emily E. Van Seventer, Isobel J. Fetter, Brandon Nadres, Christine E. Eyler, David P. Ryan, Colin D. Weekes, Jeffrey W. Clark, James C. Cusack, Lipika Goyal, Andrew X. Zhu, Jennifer Y. Wo, Lawrence S. Blaszkowsky, Jill N. Allen, Ryan B. Corcoran, Theodore S. Hong

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies

    Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies 由 Shadi A. Esfahani, Hua Ma, Shriya Krishna, Sergey Shuvaev, Mark F Sabbagh, Caitlin Deffler, Nicholas J. Rotile, Jonah Weigand‐Whittier, Iris Y. Zhou, Ciprian Catana, Onofrio A. Catalano, David T. Ting, Pedram Heidari, Eric Abston, Michael Lanuti, Genevieve M. Boland, Priyanka Pathak, Hannah Roberts, Kenneth K. Tanabe, Motaz Qadan, Carlos Fernàndez-del Castillo, Angela Shih, Aparna R. Parikh, Colin D. Weekes, Theodore S. Hong, Peter Caravan

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

    Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers 由 Aparna R. Parikh, Amikasra Mojtahed, Jaime L. Schneider, Katie Kanter, Emily E. Van Seventer, Isobel J. Fetter, Ashraf Thabet, Madeleine G. Fish, Bezaye Teshome, Kathryn Fosbenner, Brandon Nadres, Heather A. Shahzade, Jill N. Allen, Lawrence S. Blaszkowsky, David P. Ryan, Bruce J. Giantonio, Lipika Goyal, Ryan David Nipp, Eric Roeland, Colin D. Weekes, Jennifer Y. Wo, Andrew X. Zhu, Dora Dias‐Santagata, A. John Iafrate, Jochen K. Lennerz, Theodore S. Hong, Giulia Siravegna, Nora Horick, Jeffrey W. Clark, Ryan B. Corcoran

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: